Search Results - "Schaetzl, E"

Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma by Sekine, H, Hayes, D F, Ohno, T, Keefe, K A, Schaetzl, E, Bast, R C, Knapp, R, Kufe, D W

“…The murine monoclonal antibody (MAb), designated DF3, reacts with a 300-kilodalton (kd) mammary epithelial antigen. A sequential double-determinant…”
Get more information

Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer by Niloff, J M, Bast, Jr, R C, Schaetzl, E M, Knapp, R C

“…Serum CA 125 levels were evaluated in 44 patients undergoing 56 second-look or subsequent laparoscopies (43) and laparotomies (13) for ovarian cancer. In each…”
Get more information

Recombinant leukocyte alpha interferon in advanced ovarian carcinoma by Niloff, J M, Knapp, R C, Jones, G, Schaetzl, E M, Bast, Jr, R C

“…Recombinant leukocyte alpha interferon (rIFN-alpha A; Hoffmann-La Roche, Inc) was administered to 15 patients with recurrent or persistent ovarian carcinoma…”
Get more information

Elevated serum concentrations of CA-125 in patients with advanced endometriosis by Barbieri, R L, Niloff, J M, Bast, Jr, R C, Scaetzl, E, Kistner, R W, Knapp, R C

“…CA-125 is a high-molecular-weight glycoprotein that is expressed on the cell surface of some derivatives of embryonic coelomic epithelium. Based on results of…”
Get more information

CA125 antigen levels in obstetric and gynecologic patients by Niloff, J M, Knapp, R C, Schaetzl, E, Reynolds, C, Bast, Jr, R C

“…An immunoradiometric assay using a monoclonal antibody detects an antigenic determinant (CA125) that is present in more than 80% of epithelial ovarian cancers…”
Get more information

Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix by Niloff, J M, Klug, T L, Schaetzl, E, Zurawski, Jr, V R, Knapp, R C, Bast, Jr, R C

“…An immunoradiometric assay with the use of a monoclonal antibody can detect an antigenic determinant (CA125) in peripheral blood from more than 80% of patients…”
Get more information

Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen by Bast, Jr, R C, Klug, T L, Schaetzl, E, Lavin, P, Niloff, J M, Greber, T F, Zurawski, Jr, V R, Knapp, R C

“…CA 125 and CA 19-9 are antigenic determinants associated with human epithelial ovarian carcinomas. Murine monoclonal antibodies have been raised against these…”
Get more information